We are delighted to announce that the International Symposium of Metronomic Chemotherapy - Update on Multimodality Mechanisms including Immunotherapeutic Aspects will take place next March in Tapei. The meeting is being organized by Kelvin K. Tsai, MD, PhD, Associate Investigator and Attending Physician
Laboratories for Tumor Aggressiveness and Stemness, National Institute of Cancer Research, National Health Research Institutes and Associate Professor and Principal Investigator, Laboratories of Advanced Molecular Therapeutics, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan

International Symposium of Metronomic Chemotherapy - Update on Multimodality Mechanisms including Immunotherapeutic Aspects

Date: March 11, 2017 (Saturday)
Venue: Taipei Medical University
Sponsor: Taipei Medical University, National Health Research Institutes, Ministry of Science and Technology
Organizer: Taipei Medical University

Preliminary PROGRAM

09:00-09:30 Registration

Opening Remarks

09:30-09:40 Dr. Yun Yen President, Taipei Medical University

09:40-09:50 Dr. Chao-Ching Huang Dean, College of Medicine, Taipei Medical University

Keynote speech
09:50-10:50 Promise of Metronomic Chemotherapy Revealed in Preclinical Models of Advanced Metastatic Disease Dr. Robert S. Kerbel
Professor of Laboratory Medicine and Pathobiology, University of Toronto
Senior Scientist, Molecular and Cellular Biology Research, Sunnybrook Health Sciences Centre, Canada

10:50-11:10 Coffee Break

Session Chairman Dr. Li-Tzong Chen Director, National Institute of Cancer Research, National Health Research Institutes

11:10-11:40 Metronomic Chemotherapy Tempers the Stromal Response to Enhance Anti-tumor Efficacy Dr. Kelvin K. Tsai
Associate Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taiwan

11:40-12:10
Metronomic Chemotherapy and Checkpoint Inhibitors in Breast Cancer and Lymphoma Dr. Francesco Bertolini
Director, Laboratory Division of Hematology/Oncology, European Institute of Oncology, Milan, Italy

12:10-13:10 Lunch Break

Session Chairman Dr. Robert S. Kerbel
13:10-13:55 The Double Edged Sword of Cancer Therapy
Dr. Yuval Shaked Associate Professor, Vice Dean of Research, Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel

13:55-14:40 TBD
Dr. Nicolas Andre
Associate Professor Service d’Hématologie et Oncologie Pédiatrique, Centre Hospitalo-Universitaire Timone Enfants, AP-HM, and Metronomics Global Health Initiative, Marseille, France

14:40-15:00 Coffee Break

Session Chairman Dr. Gi-Shih Lien Superintendent, Taipei Medical University Wan Fang Hospital, Taiwan
15:00-15:45 TBD
15:45-16:30 TBD
16:30-17:15 TBD

Closing Remarks